With the analysis among 98,025 patents, we discovered top 487 key players by total patent application. Novartis AG, F. Hoffmann-La Roche Ltd., AstraZeneca Pharmaceutical Co., Ltd. are dominant in this area. They take 5.78% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 2,150
F. Hoffmann-La Roche Ltd.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1,576
Antwerpen, Belgium
Patent: 1,274
New York, United States
Patent: 1,067
New York, United States
Patent: 860
California, United States
Patent: 777
Les Laboratoires Servier SAS
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 723
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 701
With the analysis among 2,534 patents, we discovered top 405 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Inflazome Ltd., Cellix Bio Pvt Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
DUBLIN, Ireland
Patent: 82
Telangana, India
Patent: 79
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 53
Cambridgeshire, United Kingdom
Patent: 51
GenFleet Therapeutics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 49
NFlection Therapeutics, Inc.
Massachusetts, United States
Patent: 42
Basel-Stadt, Switzerland
Patent: 40
Essex, United Kingdom
Patent: 38
Vivace Therapeutics, Inc.
California, United States
Patent: 36
With the analysis among related 60,104 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Novartis AG, Amgen, Inc., F. Hoffmann-La Roche Ltd. take 2.51% of patent filing during this period.
Basel-Stadt, Switzerland
Patent: 556
California, United States
Patent: 496
F. Hoffmann-La Roche Ltd.
Antwerpen, Belgium
Patent: 417
New York, United States
Patent: 352
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 350
Nordrhein-Westfalen, Germany
Patent: 293
New York, United States
Patent: 284
Indiana, United States
Patent: 283
With the analysis among related 60,104 patents in last 5 years, we discover 57 new entrants. Inflazome Ltd., D.E. Shaw Research LLC, Wigen Biomedicine technology (Shanghai) Co Ltd are the most active new entrants in this area.
DUBLIN, Ireland
Patent: 82
New York, United States
Patent: 82
Wigen Biomedicine technology (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 71
Aligos Therapeutics, Inc.
California, United States
Patent: 71
Cambridgeshire, United Kingdom
Patent: 51
GenFleet Therapeutics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 49
Prelude Therapeutics, Inc.
Delaware, United States
Patent: 47
Beijing Xinkaiyuan Pharmaceutical Technology Co., Ltd.
Beijing Shi, China
Patent: 46
Massachusetts, United States
Patent: 45
Zhejiang Jinfang Pharmaceutical Co Ltd
Zhejiang Sheng, China
Patent: 43
With the analysis among 17,907 patents, we discovered top 326 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, China Pharmaceutical University, Shenyang Pharmaceutical University are dominant in this area. They take 4.29% of the total patent filing.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 272
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 220
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 176
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 166
Sichuan Sheng, China
Patent: 160
Capital University of Medical Sciences
Beijing Shi, China
Patent: 145
Zhejiang Sheng, China
Patent: 139
Guangdong Sheng, China
Patent: 138
Chinese Academy of Medical Scciences & Peking Union Medical College
Shandong Sheng, China
Patent: 128